These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
321 related items for PubMed ID: 16644338
21. Antihypertensive properties of a high-dose combination of trandolapril and verapamil-SR. Messerli F, Frishman WH, Elliott WJ, Bacher PH, Pepine CJ. Blood Press Suppl; 2007 Mar; 1():6-9. PubMed ID: 17566313 [Abstract] [Full Text] [Related]
22. Risk and Blood Pressure Control Rates Across the Spectrum of Coronary Artery Disease in Hypertensive Women: An Analysis from The INternational VErapamil SR-Trandolapril STudy (INVEST). Sava RI, Chen YE, Smith SM, Gong Y, Cooper-DeHoff RM, Keeley EC, Pepine CJ, Handberg EM. J Womens Health (Larchmt); 2020 Feb; 29(2):158-166. PubMed ID: 31403360 [Abstract] [Full Text] [Related]
27. Fixed combination trandolapril/verapamil sustained-release: a review of its use in essential hypertension. Muijsers RB, Curran MP, Perry CM. Drugs; 2002 Feb; 62(17):2539-67. PubMed ID: 12421112 [Abstract] [Full Text] [Related]
28. Global differences in blood pressure control and clinical outcomes in the INternational VErapamil SR-Trandolapril STudy (INVEST). Zineh I, Cooper-Dehoff RM, Wessel TR, Arant CB, Sleight P, Geiser EA, Pepine CJ. Clin Cardiol; 2005 Jul; 28(7):321-8. PubMed ID: 16075824 [Abstract] [Full Text] [Related]
30. A 26-week, prospective, open-label, uncontrolled, multicenter study to evaluate the effect of an escalating-dose regimen of trandolapril on change in blood pressure in treatment-naive and concurrently treated adult hypertensive subjects (TRAIL). Tytus RH, Burgess ED, Assouline L, Vanjaka A. Clin Ther; 2007 Feb; 29(2):305-15. PubMed ID: 17472822 [Abstract] [Full Text] [Related]
33. A meta-analysis of 94,492 patients with hypertension treated with beta blockers to determine the risk of new-onset diabetes mellitus. Bangalore S, Parkar S, Grossman E, Messerli FH. Am J Cardiol; 2007 Oct 15; 100(8):1254-62. PubMed ID: 17920367 [Abstract] [Full Text] [Related]
34. Regression of electrocardiographic left ventricular hypertrophy during antihypertensive therapy and reduction in sudden cardiac death: the LIFE Study. Wachtell K, Okin PM, Olsen MH, Dahlöf B, Devereux RB, Ibsen H, Kjeldsen SE, Lindholm LH, Nieminen MS, Thygesen K. Circulation; 2007 Aug 14; 116(7):700-5. PubMed ID: 17664372 [Abstract] [Full Text] [Related]
38. Association of 1-Year Blood Pressure Variability With Long-term Mortality Among Adults With Coronary Artery Disease: A Post Hoc Analysis of a Randomized Clinical Trial. Dasa O, Smith SM, Howard G, Cooper-DeHoff RM, Gong Y, Handberg E, Pepine CJ. JAMA Netw Open; 2021 Apr 01; 4(4):e218418. PubMed ID: 33914047 [Abstract] [Full Text] [Related]
39. Antihypertensive and renoprotective effects of trandolapril/verapamil combination: a meta-analysis of randomized controlled trials. Zou Z, Xu FY, Wang L, An MM, Zhang H, Shi XY. J Hum Hypertens; 2011 Mar 01; 25(3):203-10. PubMed ID: 20535140 [Abstract] [Full Text] [Related]
40. Alcohol consumption and cardiovascular risk in hypertensives with left ventricular hypertrophy: the LIFE study. Reims HM, Kjeldsen SE, Brady WE, Dahlöf B, Devereux RB, Julius S, Beevers G, De Faire U, Fyhrquist F, Ibsen H, Kristianson K, Lederballe-Pedersen O, Lindholm LH, Nieminen MS, Omvik P, Oparil S, Wedel H. J Hum Hypertens; 2004 Jun 01; 18(6):381-9. PubMed ID: 15103313 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]